Short Interest in BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Grows By 10.3%

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) saw a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 3,200 shares, an increase of 10.3% from the December 15th total of 2,900 shares. Based on an average trading volume of 154,200 shares, the short-interest ratio is currently 0.0 days.

BriaCell Therapeutics Stock Performance

Shares of NASDAQ:BCTXW opened at $0.15 on Monday. The company has a 50-day moving average price of $0.31 and a two-hundred day moving average price of $0.27. BriaCell Therapeutics has a twelve month low of $0.11 and a twelve month high of $2.30.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.